Filing Details

Accession Number:
0001140361-13-045208
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-12-09 10:26:05
Reporting Period:
2013-11-30
Filing Date:
2013-12-09
Accepted Time:
2013-12-09 10:26:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1367644 Emergent Biosolutions Inc. EBS Pharmaceutical Preparations (2834) 141902018
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1380187 Daniel Abdun-Nabi 2273 Research Blvd. Suite 400
Rockville MD 20850
Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-11-30 749 $19.08 103,373 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. Conists of shares acquired under the Emergent BioSolutions Employee Stock Purchase Plan on November 30, 2013